Article
Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia.
Atherosclerosis - 1 Jul 1990
De Knijff P, Stalenhoef A F, Mol M J, Gevers Leuven J A, Smit J, Erkelens D W, Schouten J, Frants R R, Havekes L M
Abstract excerpt
In a group of 120 patients with heterozygous familial hypercholesterolemia (FH) the influence of the apolipoprotein E (apoE) polymorphism on pre-treatment plasma lipid levels and on the response to treatment with simvastatin was studied. The apoE phenotype distribution did not differ significantly between the FH group and a sample group of the Dutch population. Differences in pre-treatment lipid levels were not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
